CD68 and mesothelioma: It has been demonstrated that a high density of CD68+ macrophages in surgical mesothelioma samples was correlated with worse patient clinical outcome [68,69,70] and their depletion with zoledronic acid strongly reduced tumor growth in mouse mesothelioma models [71].